CoronaVR
Experimental known SARS-CoV T-cell epitopes mapped to SARS-CoV-2 (2019-nCoV)
| MHC-type | SARS-Epi | SARS-S | SARS-E | SARS-P | SARS-Tox | SARS-AL | Conservancy with SARS-CoV-2 | SARS-CoV-2-Epi | SARS-CoV-2-S | SARS-CoV-2-E | SARS-CoV-2-L | SARS-CoV-2-P | SARS-CoV-2-Tox | SARS-CoV-2-AL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MHC-I | VNFNFNGL | 525 | 532 | S | NT | AL | 100.00% | VNFNFNGL | 539 | 546 | 8 | S | NT | AL |
| MHC-I | YNYKYRYL | 436 | 443 | S | NT | Non-AL | 62.50% | YNYLYRLF | 449 | 456 | 8 | S | NT | AL |
| MHC-I | ILLNKHID | 352 | 359 | N | NT | AL | 100.00% | ILLNKHID | 351 | 358 | 8 | N | NT | AL |
| MHC-I | YGVSATKL | 367 | 374 | S | NT | Non-AL | 87.50% | YGVSPTKL | 380 | 387 | 8 | S | NT | AL |
| MHC-I | HNYKYRYL | 436 | 443 | S | NT | Non-AL | 50.00% | GNYNYLYR | 447 | 454 | 8 | S | NT | AL |
| MHC-I | ALNTLVKQL | 940 | 948 | S | NT | Non-AL | 100.00% | ALNTLVKQL | 958 | 966 | 9 | S | NT | Non-AL |
| MHC-I | ALNTPKDHI | 139 | 147 | N | NT | AL | 100.00% | ALNTPKDHI | 138 | 146 | 9 | N | NT | AL |
| MHC-I | ALSGVFCGV | 2990 | 2998 | ORF1ab | NT | AL | 77.78% | SLPGVFCGV | 3013 | 3021 | 9 | ORF1ab | NT | AL |
| MHC-I | AMWLLLLSI | 2207 | 2215 | ORF1ab | NT | Non-AL | 55.56% | IIWFLLLSV | 2230 | 2238 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | AMWLLLLSI | 2207 | 2215 | ORF1ab | NT | Non-AL | 55.56% | DMILSLLSK | 7067 | 7075 | 9 | ORF1ab | NT | AL |
| MHC-I | AMWLLLLSI | 2207 | 2215 | ORF1ab | NT | Non-AL | 55.56% | ALALLLLDR | 218 | 226 | 9 | N | NT | Non-AL |
| MHC-I | CLDAGINYV | 2187 | 2195 | ORF1ab | NT | AL | 55.56% | CLEASFNYL | 2210 | 2218 | 9 | ORF1ab | NT | AL |
| MHC-I | CYGVSATKL | 366 | 374 | S | NT | Non-AL | 88.89% | CYGVSPTKL | 379 | 387 | 9 | S | NT | AL |
| MHC-I | FIAGLIAIV | 1202 | 1210 | S | NT | Non-AL | 100.00% | FIAGLIAIV | 1220 | 1228 | 9 | S | NT | Non-AL |
| MHC-I | GLMWLSYFV | 88 | 96 | M | NT | Non-AL | 88.89% | GLMWLSYFI | 89 | 97 | 9 | M | NT | Non-AL |
| MHC-I | GMSRIGMEV | 317 | 325 | N | NT | Non-AL | 100.00% | GMSRIGMEV | 316 | 324 | 9 | N | NT | Non-AL |
| MHC-I | ILLLDQVLV | 2546 | 2554 | ORF1ab | NT | Non-AL | 88.89% | ILLLDQALV | 2569 | 2577 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | ILLNKHIDA | 352 | 360 | N | NT | AL | 100.00% | ILLNKHIDA | 351 | 359 | 9 | N | NT | AL |
| MHC-I | ILPDPLKPT | 787 | 795 | S | NT | Non-AL | 77.78% | ILPDPSKPS | 805 | 813 | 9 | S | NT | Non-AL |
| MHC-I | LALLLLDRL | 220 | 228 | N | NT | Non-AL | 100.00% | LALLLLDRL | 219 | 227 | 9 | N | NT | Non-AL |
| MHC-I | LITGRLQSL | 978 | 986 | S | NT | AL | 100.00% | LITGRLQSL | 996 | 1004 | 9 | S | NT | AL |
| MHC-I | LLLDRLNQL | 223 | 231 | N | NT | AL | 100.00% | LLLDRLNQL | 222 | 230 | 9 | N | NT | AL |
| MHC-I | LQLPQGTTL | 160 | 168 | N | NT | AL | 100.00% | LQLPQGTTL | 159 | 167 | 9 | N | NT | AL |
| MHC-I | NLNESLIDL | 1174 | 1182 | S | NT | AL | 100.00% | NLNESLIDL | 1192 | 1200 | 9 | S | NT | AL |
| MHC-I | QFKDNVILL | 346 | 354 | N | NT | Non-AL | 77.78% | NFKDQVILL | 345 | 353 | 9 | N | NT | Non-AL |
| MHC-I | RLNEVAKNL | 1167 | 1175 | S | NT | AL | 100.00% | RLNEVAKNL | 1185 | 1193 | 9 | S | NT | AL |
| MHC-I | RLNQLESKV | 227 | 235 | N | NT | AL | 88.89% | RLNQLESKM | 226 | 234 | 9 | N | NT | AL |
| MHC-I | SIVAYTMSL | 673 | 681 | S | NT | AL | 88.89% | SIIAYTMSL | 691 | 699 | 9 | S | NT | AL |
| MHC-I | SMWALVISV | 3709 | 3717 | ORF1ab | NT | Non-AL | 88.89% | SMWALIISV | 3732 | 3740 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | TLMNVITLV | 3687 | 3695 | ORF1ab | NT | Non-AL | 88.89% | TLMNVLTLV | 3710 | 3718 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | VLAWLYAAV | 3444 | 3452 | ORF1ab | NT | Non-AL | 100.00% | VLAWLYAAV | 3467 | 3475 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | VLNDILSRL | 958 | 966 | S | NT | Non-AL | 100.00% | VLNDILSRL | 976 | 984 | 9 | S | NT | Non-AL |
| MHC-I | VVFLHVTYV | 1042 | 1050 | S | NT | Non-AL | 100.00% | VVFLHVTYV | 1060 | 1068 | 9 | S | NT | Non-AL |
| MHC-I | WLMWFIISI | 2340 | 2348 | ORF1ab | NT | Non-AL | 66.67% | WLMWLIINL | 2363 | 2371 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | LLCVLAALV | 2755 | 2763 | ORF1ab | NT | Non-AL | 55.56% | SACVLAAEC | 2911 | 2919 | 9 | ORF1ab | NT | Non-AL |
| MHC-I | SITAQPVKI | 12 | 20 | 3a | NT | Non-AL | 33.33% | SVTSSIVIT | 162 | 170 | 9 | 3a | NT | AL |
| MHC-I | SITAQPVKI | 12 | 20 | 3a | NT | Non-AL | 33.33% | SGVVNPVME | 253 | 261 | 9 | 3a | NT | AL |
| MHC-I | SITAQPVKI | 12 | 20 | 3a | NT | Non-AL | 44.44% | NCTEVPVAI | 616 | 624 | 9 | S | NT | AL |
| MHC-I | HLRMAGHSL | 147 | 155 | M | NT | Non-AL | 77.78% | HLRIAGHHL | 148 | 156 | 9 | M | NT | AL |
| MHC-I | GETALALLLL | 216 | 225 | N | NT | Non-AL | 80.00% | GDAALALLLL | 215 | 224 | 10 | N | NT | Non-AL |
| MHC-I | KCYGVSATKL | 365 | 374 | S | NT | Non-AL | 90.00% | KCYGVSPTKL | 378 | 387 | 10 | S | NT | AL |
| MHC-I | KLPDDFMGCV | 411 | 420 | S | NT | AL | 90.00% | KLPDDFTGCV | 424 | 433 | 10 | S | NT | AL |
| MHC-I | NYNYKYRYLR | 435 | 444 | S | NT | Non-AL | 70.00% | NYNYLYRLFR | 448 | 457 | 10 | S | NT | Non-AL |
| MHC-I | TLACFVLAAV | 60 | 69 | M | NT | Non-AL | 100.00% | TLACFVLAAV | 61 | 70 | 10 | M | NT | Non-AL |
| MHC-I | MEVTPSGTWL | 323 | 332 | N | NT | Non-AL | 100.00% | MEVTPSGTWL | 322 | 331 | 10 | N | NT | Non-AL |
| MHC-I | TKQYNVTQAF | 266 | 275 | N | NT | AL | 90.00% | TKAYNVTQAF | 265 | 274 | 10 | N | NT | AL |
| MHC-II | KCYGVSATKL | 365 | 374 | S | NT | Non-AL | 90.00% | KCYGVSPTKL | 378 | 387 | 10 | S | NT | AL |
| MHC-II | NYNYKYRYLR | 435 | 444 | S | NT | Non-AL | 70.00% | NYNYLYRLFR | 448 | 457 | 10 | S | NT | Non-AL |
| MHC-II | CTFEYISDAFSLD | 159 | 171 | S | NT | AL | 61.54% | CTFEYVSQPFLMD | 166 | 178 | 13 | S | NT | Non-AL |
| MHC-II | DAFSLDVSEKSGN | 166 | 178 | S | NT | AL | 38.46% | KPFERDISTEIYQ | 462 | 474 | 13 | S | NT | Non-AL |
| MHC-II | RPFERDISNVPFS | 449 | 461 | S | NT | Non-AL | 53.85% | KPFERDISTEIYQ | 462 | 474 | 13 | S | NT | Non-AL |
| MHC-II | YFYYLGTGPEASL | 110 | 122 | N | NT | Non-AL | 92.31% | YFYYLGTGPEAGL | 109 | 121 | 13 | N | NT | Non-AL |
| MHC-I | IGMEVTPSGTWLTYH | 321 | 335 | N | NT | AL | 93.33% | IGMEVTPSGTWLTYT | 320 | 334 | 15 | N | NT | AL |
| MHC-I | PDDQIGYYRRATRRV | 81 | 95 | N | NT | Non-AL | 93.33% | PDDQIGYYRRATRRI | 80 | 94 | 15 | N | NT | Non-AL |
| MHC-I | QKRTATKQYNVTQAF | 261 | 275 | N | NT | Non-AL | 93.33% | QKRTATKAYNVTQAF | 260 | 274 | 15 | N | NT | Non-AL |
| MHC-I | RRPQGLPNNTASWFT | 41 | 55 | N | NT | AL | 100.00% | RRPQGLPNNTASWFT | 40 | 54 | 15 | N | NT | AL |
| MHC-I | RFFTLGSITAQPVKI | 6 | 20 | 3a | NT | Non-AL | 40.00% | RIFTIGTVTLKQGEI | 6 | 20 | 15 | 3a | NT | Non-AL |
| MHC-I | RRPQGLPNNIASWFT | 41 | 55 | N | NT | AL | 93.33% | RRPQGLPNNTASWFT | 40 | 54 | 15 | N | NT | AL |
| MHC-II | ANKEGIVWVATEGAL | 126 | 140 | N | NT | AL | 86.67% | ANKDGIIWVATEGAL | 125 | 139 | 15 | N | NT | AL |
| MHC-II | AQFAPSASAFFGMSR | 306 | 320 | N | NT | Non-AL | 100.00% | AQFAPSASAFFGMSR | 305 | 319 | 15 | N | NT | Non-AL |
| MHC-II | ASWFTALTQHGKEEL | 51 | 65 | N | NT | Non-AL | 93.33% | ASWFTALTQHGKEDL | 50 | 64 | 15 | N | NT | Non-AL |
| MHC-II | ATRRVRGGDGKMKEL | 91 | 105 | N | NT | Non-AL | 86.67% | ATRRIRGGDGKMKDL | 90 | 104 | 15 | N | NT | Non-AL |
| MHC-II | FYYLGTGPEASLPYG | 111 | 125 | N | NT | Non-AL | 93.33% | FYYLGTGPEAGLPYG | 110 | 124 | 15 | N | NT | Non-AL |
| MHC-II | GKEELRFPRGQGVPI | 61 | 75 | N | NT | AL | 86.67% | GKEDLKFPRGQGVPI | 60 | 74 | 15 | N | NT | Non-AL |
| MHC-II | GNYNYKYRYLRHGKL | 434 | 448 | S | NT | Non-AL | 60.00% | GNYNYLYRLFRKSNL | 447 | 461 | 15 | S | NT | Non-AL |
| MHC-II | GYYRRATRRVRGGDG | 86 | 100 | N | NT | Non-AL | 93.33% | GYYRRATRRIRGGDG | 85 | 99 | 15 | N | NT | Non-AL |
| MHC-II | KMKELSPRWYFYYLG | 101 | 115 | N | NT | Non-AL | 93.33% | KMKDLSPRWYFYYLG | 100 | 114 | 15 | N | NT | Non-AL |
| MHC-II | PDDQIGYYRRATRRV | 81 | 95 | N | NT | Non-AL | 93.33% | PDDQIGYYRRATRRI | 80 | 94 | 15 | N | NT | Non-AL |
| MHC-II | PTDSTDNNQNGGRNG | 21 | 35 | N | NT | AL | 66.67% | PSDSTGSNQNGERSG | 20 | 34 | 15 | N | NT | Non-AL |
| MHC-II | RSAPRITFGGPTDST | 11 | 25 | N | NT | Non-AL | 86.67% | RNAPRITFGGPSDST | 10 | 24 | 15 | N | NT | Non-AL |
| MHC-II | SPRWYFYYLGTGPEA | 106 | 120 | N | NT | Non-AL | 100.00% | SPRWYFYYLGTGPE | 105 | 119 | 15 | N | NT | Non-AL |
| MHC-II | STDLIKNQCVNFNFN | 516 | 530 | S | NT | Non-AL | 80.00% | STNLVKNKCVNFNFN | 530 | 544 | 15 | S | NT | Non-AL |
| MHC-II | TPSGTWLTYHGAIKL | 326 | 340 | N | NT | Non-AL | 93.33% | TPSGTWLTYTGAIKL | 325 | 339 | 15 | N | NT | Non-AL |
| MHC-II | VILLNKHIDAYKTFP | 351 | 365 | N | NT | AL | 100.00% | VILLNKHIDAYKTFP | 350 | 364 | 15 | N | NT | AL |
| MHC-II | WLTYHGAIKLDDKDP | 331 | 345 | N | NT | AL | 93.33% | WLTYTGAIKLDDKDP | 330 | 344 | 15 | N | NT | Non-AL |
| MHC-II | SWFITQRNFFSPQII | 1083 | 1097 | S | NT | Non-AL | 73.33% | HWFVTQRNFYEPQII | 1101 | 1115 | 15 | S | NT | Non-AL |
| MHC-II | DDQIGYYRRATRRVR | 82 | 96 | N | NT | Non-AL | 93.33% | DDQIGYYRRATRRIR | 81 | 95 | 15 | N | NT | Non-AL |
| MHC-II | GDGKMKELSPRWYFY | 98 | 112 | N | NT | Non-AL | 93.33% | GDGKMKDLSPRWYFY | 97 | 111 | 15 | N | NT | Non-AL |
| MHC-II | GQGVPINTNSGPDDQ | 70 | 84 | N | NT | Non-AL | 93.33% | GQGVPINTNSSPDDQ | 69 | 83 | 15 | N | NT | Non-AL |
| MHC-II | MKELSPRWYFYYLGT | 102 | 116 | N | NT | Non-AL | 93.33% | MKDLSPRWYFYYLGT | 101 | 115 | 15 | N | NT | Non-AL |
| MHC-II | NSGPDDQIGYYRRAT | 78 | 92 | N | NT | Non-AL | 93.33% | NSSPDDQIGYYRRAT | 77 | 91 | 15 | N | NT | Non-AL |
| MHC-II | PINTNSGPDDQIGYY | 74 | 88 | N | NT | Non-AL | 93.33% | PINTNSSPDDQIGYY | 73 | 87 | 15 | N | NT | Non-AL |
| MHC-II | RATRRVRGGDGKMKE | 90 | 104 | N | NT | Non-AL | 86.67% | RATRRIRGGDGKMKD | 89 | 103 | 15 | N | NT | Non-AL |
| MHC-II | RVRGGDGKMKELSPR | 94 | 108 | N | NT | Non-AL | 86.67% | RIRGGDGKMKDLSPR | 93 | 107 | 15 | N | NT | Non-AL |
| MHC-II | AFLAVFQSATKIIAL | 51 | 65 | 3a | NT | Non-AL | 80.00% | ALLAVFQSASKIITL | 51 | 65 | 15 | 3a | NT | Non-AL |
| MHC-II | GVKDYVVVHGYFTEV | 196 | 210 | 3a | NT | AL | 66.67% | GVKDCVVLHSYFTSD | 196 | 210 | 15 | 3a | NT | Non-AL |
| MHC-II | NKRWQLALYKGFQFI | 66 | 80 | 3a | NT | AL | 66.67% | KKRWQLALSKGVHFV | 66 | 80 | 15 | 3a | NT | Non-AL |
| MHC-II | RFFTLGSITAQPVKI | 6 | 20 | 3a | NT | Non-AL | 40.00% | RIFTIGTVTLKQGEI | 6 | 20 | 15 | 3a | NT | Non-AL |
| MHC-II | YFTEVYYQLESTQIT | 206 | 220 | 3a | NT | AL | 66.67% | YFTSDYYQLYSTQLS | 206 | 220 | 15 | 3a | NT | Non-AL |
| MHC-II | GTSWFITQRNFFSPQ | 1081 | 1095 | S | NT | Non-AL | 73.33% | GTHWFVTQRNFYEPQ | 1099 | 1113 | 15 | S | NT | Non-AL |
| MHC-II | SSKRFQPFQQFGRDV | 541 | 555 | S | NT | Non-AL | 73.33% | SNKKFLPFQQFGRDI | 555 | 569 | 15 | S | NT | AL |
| MHC-II | GAALQIPFAMQMAYRF | 873 | 888 | S | NT | Non-AL | 100.00% | GAALQIPFAMQMAYRF | 891 | 906 | 16 | S | NT | Non-AL |
| MHC-II | MAYRFNGIGVTQNVLY | 884 | 899 | S | NT | Non-AL | 100.00% | MAYRFNGIGVTQNVLY | 902 | 917 | 16 | S | NT | Non-AL |
| MHC-I | LMSFPQAAPHGVVFLHV | 1031 | 1047 | S | NT | Non-AL | 94.12% | LMSFPQSAPHGVVFLHV | 1049 | 1065 | 17 | S | NT | Non-AL |
| MHC-II | ESLTTTSTALGKLQDVV | 918 | 934 | S | NT | AL | 70.59% | DSLSSTASALGKLQDVV | 936 | 952 | 17 | S | NT | AL |
| MHC-II | LLRSTSQKSIVAYTMSL | 665 | 681 | S | NT | AL | 58.82% | RARSVASQSIIAYTMSL | 683 | 699 | 17 | S | NT | AL |
| MHC-II | QALNTLVKQLSSNFGAI | 939 | 955 | S | NT | Non-AL | 100.00% | QALNTLVKQLSSNFGAI | 957 | 973 | 17 | S | NT | Non-AL |
| MHC-II | STFFSTFKCYGVSATKL | 358 | 374 | S | NT | AL | 82.35% | SASFSTFKCYGVSPTKL | 371 | 387 | 17 | S | NT | Non-AL |
| MHC-II | TECANLLLQYGSFCTQL | 729 | 745 | S | NT | Non-AL | 94.12% | TECSNLLLQYGSFCTQL | 747 | 763 | 17 | S | NT | Non-AL |
| MHC-II | VIGIINNTVYDPLQPEL | 1111 | 1127 | S | NT | Non-AL | 94.12% | VIGIVNNTVYDPLQPEL | 1129 | 1145 | 17 | S | NT | Non-AL |
| MHC-II | TNFRAILTAFSPAQDIW | 229 | 245 | S | NT | AL | 35.29% | TNMFTPLIQPIGALDIS | 3028 | 3044 | 17 | ORF1ab | NT | Non-AL |
| MHC-II | TNFRAILTAFSPAQDIW | 229 | 245 | S | NT | AL | 35.29% | VNVLAWLYAAVINGDRW | 3465 | 3481 | 17 | ORF1ab | NT | Non-AL |
| MHC-I | LLNKHIDAYKTFPPTEPK | 353 | 370 | N | NT | AL | 100.00% | LLNKHIDAYKTFPPTEPK | 352 | 369 | 18 | N | NT | AL |
| MHC-II | CSQNPLAELKCSVKSFEI | 278 | 295 | S | NT | AL | 50.00% | CALDPLSETKCTLKSFTV | 291 | 308 | 18 | S | NT | AL |
| MHC-II | IYQTSNFRVVPSGDVVRF | 299 | 316 | S | NT | Non-AL | 72.22% | IYQTSNFRVQPTESIVRF | 312 | 329 | 18 | S | NT | AL |
| MHC-II | KKISNCVADYSVLYNSTF | 343 | 360 | S | NT | AL | 83.33% | KRISNCVADYSVLYNSAS | 356 | 373 | 18 | S | NT | AL |
| MHC-II | KSFEIDKGIYQTSNFRVV | 291 | 308 | S | NT | Non-AL | 77.78% | KSFTVEKGIYQTSNFRVQ | 304 | 321 | 18 | S | NT | AL |
| MHC-II | NIDATSTGNYNYKYRYLR | 427 | 444 | S | NT | AL | 55.56% | NLDSKVGGNYNYLYRLFR | 440 | 457 | 18 | S | NT | AL |
| MHC-II | AQKFNGLTVLPPLLTDDM | 834 | 851 | S | NT | AL | 94.44% | AQKFNGLTVLPPLLTDEM | 852 | 869 | 18 | S | NT | AL |
| MHC-II | EIFRSDTLYLTQDLFLPF | 45 | 62 | S | NT | AL | 66.67% | KVFRSSVLHSTQDLFLPF | 41 | 58 | 18 | S | NT | Non-AL |
| MHC-II | GFMKQYGECLGDINARDL | 814 | 831 | S | NT | AL | 83.33% | GFIKQYGDCLGDIAARDL | 832 | 849 | 18 | S | NT | AL |
| MHC-II | KSIVAYTMSLGADSSIAY | 672 | 689 | S | NT | AL | 72.22% | QSIIAYTMSLGAENSVAY | 690 | 707 | 18 | S | NT | AL |
| MHC-II | NAFNCTFEYISDAFSLDV | 155 | 172 | S | NT | AL | 55.56% | SANNCTFEYVSQPFLMDL | 162 | 179 | 18 | S | NT | Non-AL |
| MHC-II | NPFFAVSKPMGTQTHTMI | 135 | 152 | S | NT | Non-AL | 33.33% | KPFITESKPSVEQRKQDD | 1212 | 1229 | 18 | ORF1ab | NT | Non-AL |
| MHC-II | NPFFAVSKPMGTQTHTMI | 135 | 152 | S | NT | Non-AL | 33.33% | GVSAARLTPCGTGTSTDV | 4405 | 4422 | 18 | ORF1ab | NT | Non-AL |
| MHC-II | QLIRAAEIRASANLAATK | 993 | 1010 | S | NT | AL | 100.00% | QLIRAAEIRASANLAATK | 1011 | 1028 | 18 | S | NT | AL |
| MHC-II | TAFSPAQDIWGTSAAAYF | 236 | 253 | S | NT | Non-AL | 33.33% | VTYVPAQEKNFTTAPAIC | 1065 | 1082 | 18 | S | NT | AL |
| MHC-II | TGFHTINHTFGNPVIPFK | 67 | 84 | S | NT | Non-AL | 38.89% | TWFHAIHVSGTNGTKRFD | 63 | 80 | 18 | S | NT | AL |
| MHC-II | TGFHTINHTFGNPVIPFK | 67 | 84 | S | NT | Non-AL | 38.89% | VSGTNGTKRFDNPVLPFN | 70 | 87 | 18 | S | NT | Non-AL |
| MHC-II | TGFHTINHTFGNPVIPFK | 67 | 84 | S | NT | Non-AL | 38.89% | TNFTISVTTEILPVSMTK | 716 | 733 | 18 | S | NT | Non-AL |
| MHC-II | TGFHTINHTFGNPVIPFK | 67 | 84 | S | NT | Non-AL | 38.89% | TGVHAGTDLEGNFYGPFV | 3432 | 3449 | 18 | ORF1ab | NT | AL |
| MHC-II | TLKPIFKLPLGINITNFR | 215 | 232 | S | NT | AL | 55.56% | ALEPLVDLPIGINITRFQ | 222 | 239 | 18 | S | NT | Non-AL |
| MHC-II | VKQMYKTPTLKYFGGFNF | 767 | 784 | S | NT | Non-AL | 77.78% | VKQIYKTPPIKDFGGFNF | 785 | 802 | 18 | S | NT | Non-AL |
| MHC-II | VRGWVFGSTMNNKSQSVI | 98 | 115 | S | NT | Non-AL | 50.00% | IRGWIFGTTLDSKTQSLL | 101 | 118 | 18 | S | NT | Non-AL |
| MHC-II | YLRHGKLRPFERDISNVP | 442 | 459 | S | NT | Non-AL | 50.00% | LFRKSNLKPFERDISTEI | 455 | 472 | 18 | S | NT | AL |
| MHC-II | YLTQDLFLPFYSNVTGFH | 53 | 70 | S | NT | AL | 77.78% | HSTQDLFLPFFSNVTWFH | 49 | 66 | 18 | S | NT | Non-AL |
| MHC-I | GPDDQIGYYRRATRRVRGGD | 80 | 99 | N | NT | Non-AL | 90.00% | SPDDQIGYYRRATRRIRGGD | 79 | 98 | 20 | N | NT | Non-AL |
| MHC-II | GIVWVATEGALNTPKDHIGT | 130 | 149 | N | NT | Non-AL | 95.00% | GIIWVATEGALNTPKDHIGT | 129 | 148 | 20 | N | NT | Non-AL |